University of Texas System and UT San Antonio leaders today hailed "a new era of hope, healing and discovery" for neurological patients and their families with a ribbon-cutting for the UT Health San ...

A copy of the Early Warning Report being filed by the Transferor may be obtained on the Company’s SEDAR+ profile at www.sedarplus.ca or by emailing [email protected] or calling (833) ...

You can review our SEC filings, the Registration Statement and Prospectus by accessing the SEC’s internet site at www.sec .g ov or on the Company’s website at www.quantumbiopharma.com, through which ...

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) (“Quantum BioPharma ”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech ...

An update from Quantum Biopharma ( ($TSE:QNTM) ) is now available. Quantum BioPharma Ltd. has announced an at-the-market offering agreement with ...

About 1 million people in the U.S. live with multiple sclerosis, a chronic autoimmune disease that inflames the nervous ...

In the human brain, neurofilament light chain (NfL, shown in brown) is seen in brain cells and the neural wires that connect them. UCSF researchers found NfL in the bloodstream of patients who would ...

A new study published in Scientific Reports indicates that amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS) have an extremely high geographic association, even after controlling for ...

A mum with multiple sclerosis has become the first patient in the UK to receive an experimental treatment that could slow or even stop progression of the disease. Emily Henders, 37, was given an ...

Key updates in disease-modifying therapies for relapsing-remitting multiple sclerosis (RRMS) from the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) forum are reported ...